Sravani Pulya

646 citations

18 papers · 502 indexed · h-index 13

Co-authors: Balaram Ghosh Swati Biswas Tarun Jha Nilanjan Adhikari Sk. Abdul Amin Tarun Patel Milan Paul Shovanlal Gayen
Topics: Histone Deacetylase Inhibitors Research (9 papers)Peptidase Inhibition and Analysis (7 papers)Protein Degradation and Inhibitors (6 papers)
Cited by: Organic Chemistry Oncology Molecular Biology
Journals: Journal of Medicinal Chemistry RSC Advances European Journal of Medicinal Chemistry
Partner nations: India Australia United Kingdom

In The Last Decade

Sravani Pulya

18 papers receiving 496 citations

Peers

Countries citing papers authored by Sravani Pulya

Since Specialization

Citations

This map shows the geographic impact of Sravani Pulya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sravani Pulya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sravani Pulya more than expected).

Fields of papers citing papers by Sravani Pulya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sravani Pulya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sravani Pulya. The network helps show where Sravani Pulya may publish in the future.

Co-authorship network of co-authors of Sravani Pulya

This figure shows the co-authorship network connecting the top 25 collaborators of Sravani Pulya. A scholar is included among the top collaborators of Sravani Pulya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sravani Pulya. Sravani Pulya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation 2025 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Tarun Patel,Suvankar Banerjee,(unknown),(unknown),Sravani Pulya,Swati Biswas,Nilanjan Adhikari,Balaram Ghosh	1
2	Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer 2023 ·Journal of Medicinal Chemistry ·Sravani Pulya,(unknown),Milan Paul,Nilanjan Adhikari,Suvankar Banerjee,(unknown),Swati Biswas,Tarun Jha,Balaram Ghosh	35
3	HDAC8 As an Emerging Target in Drug Discovery With Special Emphasis on Medicinal Chemistry 2023 ·Future Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Swati Biswas,Sravani Pulya,Balaram Ghosh	6
4	Design, Synthesis and Structure–Activity Relationship Studies of Novel Spirochromanone Hydrochloride Analogs As Anticancer Agents 2022 ·Future Medicinal Chemistry ·(unknown),Sravani Pulya,(unknown),Tarun Patel,Banoth Karan Kumar,Sankaranarayanan Murugesan,Balaram Ghosh,Kondapalli Venkata Gowri Chandra Sekhar	3
5	Estrogenic Activity of Tetrazole Derivatives Bearing Bisphenol Structures: Computational Studies, Synthesis, and In Vitro Assessment 2022 ·Journal of Chemical Information and Modeling ·(unknown),(unknown),Deepak Kumar,(unknown),Sravani Pulya,Balaram Ghosh,Onkar P. Kulkarni	2
6	Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer 2022 ·European Journal of Medicinal Chemistry ·Sravani Pulya,Tarun Patel,Milan Paul,Nilanjan Adhikari,Suvankar Banerjee,(unknown),Swati Biswas,Tarun Jha,Balaram Ghosh	34
7	Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model 2021 ·Bioorganic Chemistry ·(unknown),Sravani Pulya,Tarun Patel,Nilanjan Adhikari,Sk. Abdul Amin,Milan Paul,(unknown),Swati Biswas,Tarun Jha,Balaram Ghosh	20
8	Design, synthesis and biological evaluation of 7–(5–((substituted – amino)-methyl)-thiophen–2–yl)-spiro-[chroman–2,4′–piperidin]–4–one hydrochloride analogues as anticancer agents 2021 ·Bioorganic Chemistry ·(unknown),Sravani Pulya,(unknown),Tarun Patel,Banoth Karan Kumar,Sankaranarayanan Murugesan,Balaram Ghosh,Kondapalli Venkata Gowri Chandra Sekhar	14
9	Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors 2021 ·Bioorganic Chemistry ·(unknown),Sravani Pulya,Tarun Patel,Sk. Abdul Amin,Nilanjan Adhikari,Swati Biswas,Tarun Jha,Balaram Ghosh	26
10	PT3: A Novel Benzamide Class Histone Deacetylase 3 Inhibitor Improves Learning and Memory in Novel Object Recognition Mouse Model 2021 ·ACS Chemical Neuroscience ·Sravani Pulya,(unknown),Yamini Bobde,(unknown),Tarun Patel,(unknown),Swati Biswas,Vivek Sharma,Onkar P. Kulkarni,Balaram Ghosh	18
11	Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents 2020 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),Ewa Augustynowicz–Kopeć,(unknown),Balaram Ghosh,Banoth Karan Kumar,Sankaranarayanan Murugesan,Sravani Pulya,Himanshu Aggarwal,Kondapalli Venkata Gowri Chandra Sekhar	33
12	Design, synthesis, and biological evaluation of novel nicotinamide derivatives as potential histone deacetylase-3 inhibitors 2020 ·New Journal of Chemistry ·(unknown),Sravani Pulya,(unknown),Yamini Bobde,Abdalla E. A. Hassan,(unknown),Balaram Ghosh,(unknown)	21
13	HDAC6 as privileged target in drug discovery: A perspective 2020 ·Pharmacological Research ·Sravani Pulya,Sk. Abdul Amin,Nilanjan Adhikari,Swati Biswas,Tarun Jha,Balaram Ghosh	178
14	Fused Chromeno‐Thieno/Furo‐Pyridines as Potential Analogs of Lamellarin D and their Anticancer Activity Evaluation 2019 ·ChemistrySelect ·(unknown),Yamini Bobde,Sravani Pulya,Krishnan Rangan,Balaram Ghosh,Anupam Bhattacharya	13
15	Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents 2019 ·Bioorganic Chemistry ·(unknown),Sravani Pulya,Kalyan Sundar Ghosh,Parthasarathi Panda,Balaram Ghosh,Shovanlal Gayen	53
16	“Quinoline Consists of 1 H ‐1,2,3‐Triazole Hybrids: Design, Synthesis and Anticancer Evaluation” 2019 ·ChemistrySelect ·(unknown),(unknown),(unknown),(unknown),(unknown),Sravani Pulya,Balaram Ghosh	17
17	Design, synthesis and biological evaluation of 1,2,3-triazole based 2-aminobenzimidazoles as novel inhibitors of LasR dependent quorum sensing in Pseudomonas aeruginosa 2019 ·RSC Advances ·(unknown),(unknown),Shashidhar Nizalapur,Tsz Tin Yu,Sravani Pulya,Balaram Ghosh,Sankaranarayanan Murugesan,Naresh Kumar,Kondapalli Venkata Gowri Chandra Sekhar	20
18	Re-engineering of PIP3-antagonist triazole PITENIN's chemical scaffold: development of novel antifungal leads 2016 ·RSC Advances ·Sravani Pulya,Yadagiri Kommagalla,Duhita G. Sant,(unknown),Santosh G. Tupe,Mukund V. Deshpande,Chepuri V. Ramana	8

About Sravani Pulya

Sravani Pulya is a scholar working on Organic Chemistry, Oncology and Toxicology, having authored 18 papers that have together received 502 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (9 papers), Peptidase Inhibition and Analysis (7 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Organic Chemistry (184 citations), Oncology (148 citations) and Molecular Biology (363 citations). Sravani Pulya has collaborated with scholars based in India, Australia and United Kingdom. Frequent co-authors include Balaram Ghosh, Swati Biswas, Tarun Jha, Nilanjan Adhikari, Sk. Abdul Amin, Tarun Patel, Milan Paul, Shovanlal Gayen, Parthasarathi Panda and Kalyan Sundar Ghosh. Their work appears in journals such as Journal of Medicinal Chemistry, RSC Advances and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact